Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction Results of the EXCELLENT Trial

Overview of attention for article published in JACC: Heart Failure, September 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 4 news outlets
twitter: 1 X user

wikipedia: 1 Wikipedia page

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 1 X post from an account with 132 followers.

🚀Exciting Milestone for @CellProthera! We are thrilled to share the peer-reviewed publication of our Phase I/IIb EXCELLENT trial results in JACC: Heart Failure. 📰You can read the full article, here 👉 https://t.co/uChI6TxfYW #Innovation #heartfailu…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.